» Articles » PMID: 16258538

Platelets Mediate Cytotoxic T Lymphocyte-induced Liver Damage

Overview
Journal Nat Med
Date 2005 Nov 1
PMID 16258538
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

We found that platelet depletion reduces intrahepatic accumulation of virus-specific cytotoxic T lymphocytes (CTLs) and organ damage in mouse models of acute viral hepatitis. Transfusion of normal but not activation-blocked platelets in platelet-depleted mice restored accumulation of CTLs and severity of disease. In contrast, anticoagulant treatment that prevented intrahepatic fibrin deposition without reducing platelet counts did not avert liver injury. Thus, activated platelets contribute to CTL-mediated liver immunopathology independently of procoagulant function.

Citing Articles

Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD.

Termite F, Archilei S, DAmbrosio F, Petrucci L, Viceconti N, Iaccarino R Antioxidants (Basel). 2025; 14(1).

PMID: 39857390 PMC: 11759774. DOI: 10.3390/antiox14010056.


Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis.

Wang J, Qiu K, Zhou S, Gan Y, Jiang K, Wang D Ann Med. 2025; 57(1):2455539.

PMID: 39834076 PMC: 11753015. DOI: 10.1080/07853890.2025.2455539.


Association between antithrombotic agents use and hepatocellular carcinoma risk: a two-sample mendelian randomization analysis.

Yang F, Li O, Gao B, Chen Z, Li B, He J J Cancer Res Clin Oncol. 2024; 150(10):470.

PMID: 39436427 PMC: 11496351. DOI: 10.1007/s00432-024-05960-7.


Liver Cancer Etiology: Old Issues and New Perspectives.

Chen J, Zhang Y, Lu J, Kensler T Curr Oncol Rep. 2024; 26(11):1452-1468.

PMID: 39388026 DOI: 10.1007/s11912-024-01605-7.


Aspirin suppresses hepatocellular carcinoma progression by inhibiting platelet activity.

Zhao L, Wang Z, Liu W, Yu L, Qi H, Ren J World J Gastrointest Oncol. 2024; 16(6):2742-2756.

PMID: 38994144 PMC: 11236245. DOI: 10.4251/wjgo.v16.i6.2742.


References
1.
McClary H, Koch R, Chisari F, Guidotti L . Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol. 2000; 74(5):2255-64. PMC: 111707. DOI: 10.1128/jvi.74.5.2255-2264.2000. View

2.
Ware J, Russell S, Ruggeri Z . Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci U S A. 2000; 97(6):2803-8. PMC: 16010. DOI: 10.1073/pnas.050582097. View

3.
Guidotti L, Chisari F . Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol. 2001; 19:65-91. DOI: 10.1146/annurev.immunol.19.1.65. View

4.
Wilson J . Adenovirus-mediated gene transfer to liver. Adv Drug Deliv Rev. 2001; 46(1-3):205-9. DOI: 10.1016/s0169-409x(00)00125-3. View

5.
Kakimi K, Lane T, Wieland S, Asensio V, Campbell I, Chisari F . Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med. 2001; 194(12):1755-66. PMC: 2193580. DOI: 10.1084/jem.194.12.1755. View